Revlimid-NIS: Non-interventional study on therapy of relapsed/ refractory multiple myeloma with a combination of Lenalidomide plus Dexamethasone

Knauf, W., Aldaoud, A., Maintz, C., Groschek, M., Teichmann, B., Harde, J., Trarbach Tanja, 2015.

Oncol Res Treat 38 (suppl.5)(P783), 238. doi:10.1159/000439070

Studie: Revlimid-NIS; Indikation: Hämoblastosen; Jahr: 2015; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com